In Parkinson’s disease, reduced Nrf2 signaling accelerates dopaminergic neuron loss, and heightened HDAC1 activity contributes to mitochondrial dysfunction and α-synuclein aggregation [4,5,6]. This evidence concerns the gene NFE2L2 and Parkinson disease.